Lista de obras - Sabine Mihm - Dominio Público Uruguay

Activation of Type I and Type III Interferons in Chronic Hepatitis C.

artículo científico

Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study

artículo científico publicado en 2015

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes

scientific article published on 28 April 2020

Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats

artículo científico publicado en 2014

Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver

artículo científico publicado en 2018

Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver

artículo científico publicado en 2014

Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?

artículo científico publicado en 2014

Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1.

artículo científico publicado en 2012

Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection

artículo científico publicado en 2009

Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy

artículo científico publicado en 2014

Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B.

artículo científico publicado en 2003

Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein

artículo científico publicado en 2013

Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity.

artículo científico publicado en 2009

Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment ⬇️

artículo científico publicado el 15 de septiembre de 2010

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.

artículo científico publicado en 2015

Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes

artículo científico publicado en 2010

Host response to hepatitis C virus

artículo científico publicado en 2005

Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.

artículo científico publicado en 2006

Interferon type I gene expression in chronic hepatitis C.

artículo científico publicado en 2004

Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes

artículo científico publicado en 2008

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

artículo científico publicado en 2002

Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data

scientific article published on 23 November 2020

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples

artículo científico publicado en 2013

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

artículo científico publicado en 2006

Ninety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821.

artículo científico publicado en 2014

Relating serum GGT to ALT activity enhances its predictability on treatment outcome in chronic hepatitis C.

artículo científico publicado en 2014

Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection

artículo científico publicado en 2003

Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates

artículo científico publicado en 2007

TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.

artículo científico publicado en 2009

Toll‐like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection ⬇️

artículo científico publicado el 1 de noviembre de 2010

Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients

artículo científico publicado en 2005

Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy

artículo científico publicado en 2011

Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection

artículo científico publicado en 2013

Lista de obras de Sabine Mihm

Activation of Type I and Type III Interferons in Chronic Hepatitis C.

Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes

Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats

Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver

Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver

Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?

Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1.

Endotoxin receptor CD14 gene variants and histological features in chronic HCV infection

Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy

Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B.

Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein

Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity.

Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment ⬇️

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.

Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes

Host response to hepatitis C virus

Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.

Interferon type I gene expression in chronic hepatitis C.

Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

Ninety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821.

Relating serum GGT to ALT activity enhances its predictability on treatment outcome in chronic hepatitis C.

Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection

Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates

TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.

Toll‐like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection ⬇️

Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients

Ultra-rapid virological response, young age, low γ-GT/ALT-ratio, and absence of steatosis identify a subgroup of HCV Genotype 3 patients who achieve SVR with IFN-α(2a) monotherapy

Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection